Literature DB >> 12725576

Dose dependent hypoglycemic effect of aqueous extract of Enicostemma littorale blume in alloxan induced diabetic rats.

J Maroo1, V T Vasu, S Gupta.   

Abstract

Previous studies in our lab had confirmed the blood glucose lowering effect of E. littorale Blume in alloxan induced diabetic rats with no change in normoglycemic control rats. Present paper deals with dose dependent (0.5, 1.0, 1.5, 2.5, 3.5 g dry plant equivalent extract/100 g body wt., p.o.) blood glucose lowering effect of aqueous extract of E. littorale Blume in alloxan induced diabetic rats. The effective dose was found to be 1.5 g dry plant equivalent extract/100 g body wt.. The above dose caused significant decrease in glycosylated haemoglobin, liver glucose-6-phosphatase activity and significant increase in serum insulin levels of the diabetic rats. No significant changes were observed in the toxicity parameters of extract treated diabetic rats as compared to diabetic control rats. The above results suggest that E. littorale is a potent antidiabetic agent without any toxic effect at this particular dose (1.5 g dry plant equivalent extract/100 g body wt.).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725576     DOI: 10.1078/094471103321659933

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  10 in total

Review 1.  Pharmacognosy of Enicostemma littorale: a review.

Authors:  Rajamani Saranya; Thirunavukkarasu Thirumalai; Munisami Hemalatha; Ranganathan Balaji; Ernest David
Journal:  Asian Pac J Trop Biomed       Date:  2013-01

2.  Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced β-cell damage in Wistar rat pancreas.

Authors:  G Dhanavathy
Journal:  J Endocrinol Invest       Date:  2015-03-15       Impact factor: 4.256

3.  Investigation of phytoconstituents of Enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitus.

Authors:  Altaf Khan; Aziz Unnisa; Mo Sohel; Mohan Date; Nayan Panpaliya; Shweta G Saboo; Falak Siddiqui; Sharuk Khan
Journal:  In Silico Pharmacol       Date:  2021-12-02

4.  Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer-407-induced hyperlipidaemic rats.

Authors:  Hitesh Vaidya; Mandapati Rajani; Vasudevan Sudarsanam; Harish Padh; Ramesh Goyal
Journal:  J Nat Med       Date:  2009-07-25       Impact factor: 2.343

5.  Biochemical Evaluation of the Hypoglycemic Effects of Extract and Fraction of Cassia fistula Linn. in Alloxan-induced Diabetic Rats.

Authors:  E E Jarald; S B Joshi; D C Jain; S Edwin
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

6.  Antidiabetic activity of Pongamia pinnata leaf extracts in alloxan-induced diabetic rats.

Authors:  Mukesh S Sikarwar; M B Patil
Journal:  Int J Ayurveda Res       Date:  2010-10

7.  Indian herbs and herbal drugs used for the treatment of diabetes.

Authors:  Manisha Modak; Priyanjali Dixit; Jayant Londhe; Saroj Ghaskadbi; Thomas Paul A Devasagayam
Journal:  J Clin Biochem Nutr       Date:  2007-05       Impact factor: 3.114

8.  Swertisin an Anti-Diabetic Compound Facilitate Islet Neogenesis from Pancreatic Stem/Progenitor Cells via p-38 MAP Kinase-SMAD Pathway: An In-Vitro and In-Vivo Study.

Authors:  Nidheesh Dadheech; Abhay Srivastava; Neha Paranjape; Shivika Gupta; Arpita Dave; Girish M Shah; Ramesh R Bhonde; Sarita Gupta
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  The Protective Effects of Securigera securidaca Seed Extract on Liver Injury Induced by Bile Duct Ligation in Rats.

Authors:  Zahra Nasehi; Nejat Kheiripour; Maryam Akhavan Taheri; Abolfazl Ardjmand; Faezeh Jozi; Esmat Aghadavod; Amir Hossein Doustimotlagh; Mohammad Esmaeil Shahaboddin
Journal:  Biomed Res Int       Date:  2022-02-04       Impact factor: 3.411

10.  Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development.

Authors:  Nur Sakinah Muhamad Fadzil; Mahendran Sekar; Siew Hua Gan; Srinivasa Reddy Bonam; Yuan Seng Wu; Jaishree Vaijanathappa; Subban Ravi; Pei Teng Lum; Shivsharan B Dhadde
Journal:  Drug Des Devel Ther       Date:  2021-06-21       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.